Cibus, Inc. (CBUS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Cibus, Inc. (CBUS) closed at USD 1.40 on 2026-10-14, a change of -11.9 % over the past year, with a market capitalization of USD 98.59M.

Cibus, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Cibus, Inc. key figures

Previous close

USD 1.40 (2026-10-14)

1-year change

-11.9 %

Market cap

USD 98.59M

Enterprise value

USD 364.43M

P/E ratio (trailing)

-0.87

P/E ratio (forward)

-2.03

EPS (trailing)

-1.49

EPS (forward)

-0.64

PEG ratio

n/a

Price to book

6.65

Revenue growth

6.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

27.93

Employees

118

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Cibus, Inc.

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Cibus, Inc. and compare it with other stocks.